ES2184096T3 - Metodo para producir peptidos. - Google Patents

Metodo para producir peptidos.

Info

Publication number
ES2184096T3
ES2184096T3 ES97927386T ES97927386T ES2184096T3 ES 2184096 T3 ES2184096 T3 ES 2184096T3 ES 97927386 T ES97927386 T ES 97927386T ES 97927386 T ES97927386 T ES 97927386T ES 2184096 T3 ES2184096 T3 ES 2184096T3
Authority
ES
Spain
Prior art keywords
peptide
formula
defined above
optionally
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97927386T
Other languages
English (en)
Inventor
Chitoshi Hatanaka
Yasuaki Abe
Mitsuhisa Yamano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2184096T3 publication Critical patent/ES2184096T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE UN PEPTIDO DE FORMULA (I): 5 - OXO - PRO - R SUP,1 - TRP - SER - R 2 - R 3 - R 4 - ARG - PRO R 6 , DONDE R 1 REPRESENTA HIS, TYR, TRP O P - NH SUB,2 - PHE; R 2 REPRESENTA TYR O PHE; R 3 REPRESENTA GLY OPCIONALMENTE SUSTITUIDO O UN RESIDUO DE AL - D - AMINOACIDO OPCIONALMENTE SUSTITUIDO; R 4 REPRESENTA LEU, ILE O NLE; R 6 REPRESENTA (1) GLY - NH - R 7 , DONDE, R SUP,7 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO QUE PUEDE ESTAR OPCIONALMENTE SUSTITUIDO POR UN GRUPO HIDROXILO, O (2) NH R 8 , DONDE, R 8 REPRESENTA UN ATOMO DE HIDROGE NO, UN GRUPO ALQUILO QUE PUEDE ESTAR OPCIONALMENTE SUSTITUIDO POR UN GRUPO HIDROXILO O UN GRUPO UREIDO (- NH - CO - NH 2). DICHO PEPTIDO SE PRODUCE VENTAJOSAMENTE A ESCALA INDUSTRIAL MEDIANTE LA REACCION DE UN PEPTIDO DE FORMULA (II): 5 - OXO PRO - R 1 TRP - SER - R 2 - R 3 - OH, DONDE, R SUP,1 , R 2 Y R 3 TIENEN EL MISMO SIGNIFICADO CITADO ANTERIORMENTE O SUS SALES, CON UN PEPTIDO DE FORMULA (III): H - R 4 - R 5 PRO - R 6 , DONDE, R 4 Y R 6 TIENEN EL MISMO SIGNIFICADO QUE LOS CITADOS ANTERIORMENTE Y R 5 REPRESENTA ARG PROTEGIDA, O SUS SALES. DICHA REACCION PRODUCE UN PEPTIDO DE FORMULA (I''): 5 - OXO - PRO - R 1 TRP - SER - R 2 R 3 - R 4 - R 5 - PRO - R SUP,6 , DONDE R 1 , R 2 , R 2 , R 3 , R 4 , R 5 Y R 6 TIENEN EL MISMO SIGNIFICADO QUE EL DEFINIDO ANTERIORMENTE, O SUS SALES. LUEGO SE SOMETE EL PEPTIDO (I'') ASI OBTENIDO A UNA REACCION CON UN GRUPO DE DESPROTECCION.
ES97927386T 1996-06-21 1997-06-19 Metodo para producir peptidos. Expired - Lifetime ES2184096T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16179196 1996-06-21

Publications (1)

Publication Number Publication Date
ES2184096T3 true ES2184096T3 (es) 2003-04-01

Family

ID=15741986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97927386T Expired - Lifetime ES2184096T3 (es) 1996-06-21 1997-06-19 Metodo para producir peptidos.

Country Status (13)

Country Link
US (1) US6211333B1 (es)
EP (1) EP0910575B1 (es)
KR (1) KR100459978B1 (es)
CN (1) CN1129607C (es)
AT (1) ATE224912T1 (es)
AU (1) AU3189997A (es)
CA (1) CA2257381C (es)
DE (1) DE69715860T2 (es)
DK (1) DK0910575T3 (es)
ES (1) ES2184096T3 (es)
IL (3) IL163521A0 (es)
PT (1) PT910575E (es)
WO (1) WO1997048726A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
NZ529822A (en) 1999-01-22 2005-11-25 Elan Pharm Inc Acyl derivatives which treat VLA-4 related disorders
EP1612215A1 (en) * 1999-01-26 2006-01-04 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
ATE341562T1 (de) * 1999-06-30 2006-10-15 Takeda Pharmaceutical Verfahren zur darstellung von lh-rh-derivaten
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
EP1545235B1 (en) * 2002-07-29 2013-11-06 Aminotech AS Method for production of peptides and amino acids from protein-comprising material of animal origin
ATE452145T1 (de) * 2005-05-03 2010-01-15 Novetide Ltd Verfahren zur herstellung von peptidderivaten
NZ567270A (en) 2005-09-29 2011-06-30 Elan Pharm Inc Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
CA2624524C (en) 2005-09-29 2014-07-08 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
AU2007220068B2 (en) 2006-02-27 2012-09-13 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4
CN102459179A (zh) 2009-04-27 2012-05-16 艾伦药物公司 α-4整联蛋白的吡啶酮拮抗剂
JP6564539B1 (ja) * 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法
CN113527438A (zh) * 2021-08-30 2021-10-22 湖南三太药业有限公司 一种全液相合成丙氨瑞林的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947569A (en) * 1972-04-12 1976-03-30 American Home Products Corporation Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor
US3855198A (en) 1972-09-29 1974-12-17 American Home Prod Novel intermediates for synthesis of l-(5-oxoprolyl)-l-histidy-l-tryptophyl-l-seryl-l-tyrosyl-l-glycyl-l-leucyl-l-arginyl-l-prolyl-glycine amide
JPS49100081A (es) 1973-01-30 1974-09-20
CA1023350A (en) 1974-01-21 1977-12-27 Manfred K. Gotz Derivatives of the lh- and fsh-releasing hormone
CH611878A5 (es) 1974-07-04 1979-06-29 Takeda Chemical Industries Ltd
EP0033976B1 (en) 1980-02-12 1984-05-30 Takeda Chemical Industries, Ltd. Method for protecting guanidino group and restoring the same
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
EP0400065B1 (en) * 1988-02-10 1997-08-27 TAP Pharmaceuticals Inc. Lhrh analog

Also Published As

Publication number Publication date
ATE224912T1 (de) 2002-10-15
KR100459978B1 (ko) 2005-01-15
DE69715860D1 (de) 2002-10-31
EP0910575B1 (en) 2002-09-25
CA2257381C (en) 2007-08-21
PT910575E (pt) 2003-02-28
WO1997048726A1 (en) 1997-12-24
IL163521A0 (en) 2005-12-18
KR20000016798A (ko) 2000-03-25
CN1222916A (zh) 1999-07-14
IL163521A (en) 2007-07-04
DK0910575T3 (da) 2003-02-03
CN1129607C (zh) 2003-12-03
CA2257381A1 (en) 1997-12-24
DE69715860T2 (de) 2003-08-07
IL127312A0 (en) 1999-09-22
US6211333B1 (en) 2001-04-03
AU3189997A (en) 1998-01-07
EP0910575A1 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
ES2184096T3 (es) Metodo para producir peptidos.
SE8403931L (sv) Treo-3-amino-2-hydroxi-4-oxosmorsyraderivat
NO911787D0 (no) Peptidaminer samt fremgangsmaate for fremstilling derav.
KR860007287A (ko) N.n'-디알킬구아니디노 디펩티드의 제조방법
DE69015811D1 (de) Insulinverbindungen.
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
ES8200645A1 (es) Un procedimiento para la preparacion de un muramildipeptido.
ES8704974A1 (es) Procedimiento para la obtencion de derivados de oligopeptido, de efecto tensioactivo compatible con la piel
ES2074699T3 (es) Sintesis y utilizacion de fluoruros de aminoacidos como reactivos para unir peptidos.
AU2308695A (en) Agents and a process for waterproofing leather and furs
KR900009692A (ko) 레트로바이러스 프로테아제 억제제
ES461987A3 (es) Procedimiento para la fabricacion de nuevos gona-4,9 (10) dienos.
IE41052B1 (en) Crop protection composition and method of application, whereby the drift of spraying liquids may be reduced
ES453304A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoacidos.
HRP20000733B1 (en) NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
JPS6429347A (en) Amide derivative and external agent for skin containing said derivative
EP0264802A3 (en) Synthesis of peptide-aminoalkyl amides and peptide hydrazides by the solid phase method
NO981051L (no) Peptidderivater
JPS572213A (en) Cosmetic
ES8106695A1 (es) Un procedimiento para la pre-paracion de un peptido.
DE59602077D1 (de) Verfahren zur Herstellung von (4,5)-trans-Oxazolidin-derivaten
ATE18206T1 (de) Verfahren zur herstellung eines laktams.
DE69428401D1 (de) Verfahren zur Herstellung von alpha-Aminosäureamiden zur Verwendung in der Peptidsynthese
US4087417A (en) Hexapeptides and methods for their production
JPS55127353A (en) Gamma-rearrangement of alpha-glutamylpeptide